Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Jean-Louis Excler

A Phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C-modified vaccinia Ankara virus vaccine candidate in Indian volunteers

scientific article published in November 2009

A joint clinical research center in Thailand: role in HIV vaccine development.

scientific article published in March 2003

A phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C adeno-associated virus vaccine

scientific article published in June 2008

A phase I double blind, placebo-controlled, randomized study of a multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults

scientific article

A randomized, observer-blinded, equivalence trial comparing two variations of Euvichol®, a bivalent killed whole-cell oral cholera vaccine, in healthy adults and children in the Philippines

scientific article published on 9 June 2018

A strategy for accelerating the development of preventive AIDS vaccines

scientific article published on 01 November 2007

AIDS vaccine development: perspectives, challenges & hopes

scientific article

AIDS vaccine efficacy trials: expand capacity and prioritize. 'Throughout Africa, Asia and Latin America state-of-the-art clinics and laboratories...exist where, 4 years ago, there were none'

scientific article published on 01 April 2006

AIDS vaccines and preexposure prophylaxis: is synergy possible?

scientific article

Accelerating the development of a group A Streptococcus vaccine: an urgent public health need

scientific article published in July 2016

Accuracy of Clinical Diagnosis of Dengue Episodes in the RV144 HIV Vaccine Efficacy Trial in Thailand

scientific article

An HIV Vaccine for South-East Asia-Opportunities and Challenges

scientific article published on 14 August 2013

An overview of VaxchoraTM, a live attenuated oral cholera vaccine

scientific article published on 20 September 2019

Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women

scientific article

Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse events

scientific article

Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial.

scientific article

Boosting with AIDSVAX B/E Enhances Env Constant Region 1 and 2 Antibody-Dependent Cellular Cytotoxicity Breadth and Potency

scientific article published on 31 January 2020

Broad HIV epitope specificity and viral inhibition induced by multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults

scientific article

Characterization of HIV-1 gp120 antibody specificities induced in anogenital secretions of RV144 vaccine recipients after late boost immunizations

scientific article published on 27 April 2018

Comparison of Antibody Responses Induced by RV144, VAX003, and VAX004 Vaccination Regimens

scientific article

Development of Middle East Respiratory Syndrome Coronavirus vaccines - advances and challenges

scientific article

Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial

scientific article published on 14 March 2018

Expanding research capacity and accelerating AIDS vaccine development in Asia

scientific article

Expectation of volunteers towards the vaccine efficacy of the prime-boost HIV vaccine phase III trial during unblinding

scientific article

First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens

scientific article published on 17 October 2016

HIV Epidemic in Asia: Implications for HIV Vaccine and Other Prevention Trials

scientific article

HIV Vaccine Efficacy and Immune Correlates of Risk ⬇️

scientific article published on September 1, 2013

HIV epidemic in Asia: optimizing and expanding vaccine development ⬇️

scientific article published on July 1, 2012

HIV prevention & treatment--reasons to rejoice & remain vigilant

scientific article published on December 2015

HIV vaccine delayed boosting increases Env variable region 2-specific antibody effector functions

scientific article published on 30 January 2020

HIV vaccines: lessons learned and the way forward ⬇️

scientific article published on September 1, 2010

HIV-1 vaccines: challenges and new perspectives

scientific article

Heterologous prime-boost regimens using rAd35 and rMVA vectors elicit stronger cellular immune responses to HIV proteins than homologous regimens

scientific article

IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens

scientific article

Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation

scientific article

Lessons from HIV-1 vaccine efficacy trials

scientific article published on 16 August 2016

Lessons from the RV144 Thai phase III HIV-1 vaccine trial and the search for correlates of protection

scientific article

Lessons learnt from 12 oral cholera vaccine campaigns in resource-poor settings

scientific article

Letter to the Editor on: The RV144 vaccine regimen was not associated with enhancement of infection

scientific article published on January 2015

Live virus vaccines based on a yellow fever vaccine backbone: standardized template with key considerations for a risk/benefit assessment

scientific article

New prospects for a preventive HIV-1 vaccine

scientific article

Nonneutralizing functional antibodies: a new "old" paradigm for HIV vaccines

scientific article

Novel directions in HIV-1 vaccines revealed from clinical trials ⬇️

scientific article published on September 1, 2013

Novel prime-boost vaccine strategies against HIV-1

scientific article published on 09 July 2019

Preparedness for AIDS vaccine trials in India

scientific article published on June 2008

Prevalence of specific neutralizing antibodies against Sendai virus in populations from different geographic areas: implications for AIDS vaccine development using Sendai virus vectors

scientific article published in June 2011

Prospects for a Globally Effective HIV-1 Vaccine

scientific article published on December 2015

Prospects for a globally effective HIV-1 vaccine

scientific article published on 19 June 2015

Randomized, Double-Blind Evaluation of Late Boost Strategies for HIV-Uninfected Vaccine Recipients in the RV144 HIV Vaccine Efficacy Trial

scientific article

Research and development of new vaccines against infectious diseases

article

Safety and Immunogenicity of a Randomized Phase 1 Prime-Boost Trial With ALVAC-HIV (vCP205) and Oligomeric Glycoprotein 160 From HIV-1 Strains MN and LAI-2 Adjuvanted in Alum or Polyphosphazene

scientific article published on 11 February 2016

Safety and immunogenicity of DNA and MVA HIV-1 subtype C vaccine prime-boost regimens: a phase I randomised Trial in HIV-uninfected Indian volunteers

scientific article

Safety and immunogenicity of a Vi-DT typhoid conjugate vaccine: Phase I trial in Healthy Filipino adults and children

scientific article published in June 2018

Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination in an efficacy trial in Thailand

scientific article published in 2011

Safety of a bivalent, killed, whole-cell oral cholera vaccine in pregnant women in Bangladesh: evidence from a randomized placebo-controlled trial

scholarly article by Ashraful Islam Khan et al published 15 May 2019 in BMC Infectious Diseases

Six-month follow up of a randomized clinical trial-phase I study in Indonesian adults and children: Safety and immunogenicity of Salmonella typhi polysaccharide-diphtheria toxoid (Vi-DT) conjugate vaccine

article by Bernie Endyarni Medise et al published 2019 in PLOS ONE

Stakeholder Engagement in HIV Cure Research: Lessons Learned from Other HIV Interventions and the Way Forward

scientific article published on 18 May 2015

The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG).

scientific article

The HIV-1 gp120 V1V2 loop: structure, function and importance for vaccine development

scientific article

The US Military Commitment to Vaccine Development: A Century of Successes and Challenges

scientific article

The path to group A Streptococcus vaccines: WHO research and development technology roadmap and preferred product characteristics

article

Toward Developing a Preventive MERS-CoV Vaccine-Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14-15, 2015.

scientific article published on August 2016

Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strains

scientific article published on 23 June 2016

Vaccines to prevent transmission of HIV-1 via breastmilk: scientific and logistical priorities

scientific article published on August 2006

Paulina is supported by:

About Paulina

Help